SCHEMBL297939

SCHEMBL297939

C=C(CN)CC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL377180 0.81 LDHA (0.57)
SCHEMBL7931508 0.74
SCHEMBL12927368 0.74 KDM4E (0.44)
Glycine SCHEMBL3457792 0.74
SCHEMBL18432281 0.73
SCHEMBL122476 0.71
Glycine SCHEMBL8095196 0.70
Glycine SCHEMBL21879657 0.70 GLRA1 (0.83)
Glycine SCHEMBL6239942 0.70 GLRA1 (0.83)
Glycine SCHEMBL8585762 0.70 GLRA1 (0.83)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9101662-B2 Compositions with modulating agents FOAMIX PHARMACEUTICALS LTD. (IL) 2015-08-11 US claimed
US-8795693-B2 Compositions with modulating agents FOAMIX LTD. (IL) 2014-08-05 US claimed
EP-2097065-A2 FOAMABLE WATERLESS COMPOSITIONS WITH MODULATING AGENTS Foamix Ltd. (IL) 2009-09-09 EP claimed
WO-2008152444-A2 FOAMABLE WATERLESS COMPOSITIONS WITH MODULATING AGENTS FOAMIX LTD. (US) 2008-12-18 WO claimed
US-20080206159-A1 Drug mixture contains solvents, nonionic surfactants, gelling agent, therapeutic active agent, liquefied or compressed gas propellant; pressurized dispenser; treating skin diseases, dermal and mucosal delivery; stable and non-irritating emulsions FOAMIX LTD. (IL) 2008-08-28 US claimed
US-9101662-B2 Compositions with modulating agents FOAMIX PHARMACEUTICALS LTD. (IL) 2015-08-11 US disclosed
US-8795693-B2 Compositions with modulating agents FOAMIX LTD. (IL) 2014-08-05 US disclosed
US-20140080140-A1 SCREENING FOR NEUROTOXIC AMINO ACID ASSOCIATED WITH NEUROLOGICAL DISORDERS THE INSTITUTE FOR ETHNOMEDICINE 2014-03-20 US disclosed
US-8541184-B2 Screening for neurotoxic amino acid associated with neurological disorders THE INSTITUTE FOR ETHNOMEDICINE (US) 2013-09-24 US disclosed
US-8222276-B2 Amine salt of carbostyril derivative OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2012-07-17 US disclosed
EP-2253619-B1 Amine salt of carbostyril derivative OTSUKA PHARMA CO LTD (JP) 2012-03-14 EP disclosed
EP-1860441-B1 Neurotoxic amino acid or neurotoxic derivative thereof associated with neurological disorders INST ETHNOMEDICINE (US) 2011-08-10 EP disclosed
EP-1664793-B1 NEUROTOXIC AMINO ACID OR NEUROTOXIC DERIVATIVE THEREOF ASSOCIATED WITH NEUROLOGICAL DISORDERS INST ETHNOMEDICINE (US) 2007-11-07 EP disclosed
US-20070254315-A1 SCREENING FOR NEUROTOXIC AMINO ACID ASSOCIATED WITH NEUROLOGICAL DISORDERS THE INSTITUTE FOR ETHNOMEDICINE (US) 2007-11-01 US disclosed
US-7256002-B2 Screening for neurotoxic amino acid associated with neurological disorders THE INSTITUTE FOR ETHNOMEDICINE (US) 2007-08-14 US disclosed
US-20070155787-A1 Amine salt of carbostyril derivative OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-07-05 US disclosed
CN-1860369-A Neurotoxic amino acid or neurotoxic derivative thereof associated with neurological disorders NAT TROPICAL BOTAN GARDEN (US) 2006-11-08 CN disclosed
EP-1664793-A1 NEUROTOXIC AMINO ACID OR NEUROTOXIC DERIVATIVE THEREOF ASSOCIATED WITH NEUROLOGICAL DISORDERS Institute For Ethnomedicine (US) 2006-06-07 EP disclosed
WO-2005019830-A1 NEUROTOXIC AMINO ACID OR NEUROTOXIC DERIVATIVE THEREOF ASSOCIATED WITH NEUROLOGICAL DISORDERS INSTITUTE FOR ETHNOMEDICINE (US) 2005-03-03 WO disclosed
US-20050042686-A1 Neurotoxic amino acid or neurotoxic derivative thereof associated with neurological disorders NATIONAL TROPICAL BOTANICAL GARDEN 2005-02-24 US disclosed